View More Recent Stories

Mar 16, 2022 07:00AM Karyopharm Announces Upcoming Presentations of Phase 3 SIENDO Study of Selinexor in Patients with Advanced or Recurrent Endometrial Cancer
Mar 14, 2022 07:00AM Karyopharm Names New Head of Investor Relations
Mar 9, 2022 07:00AM Karyopharm to Participate at the Barclays Global Healthcare Conference
Mar 1, 2022 04:10PM Karyopharm Therapeutics (KPTI) receives FDA feedback that the current SIENDO study top-line results are unlikely to support an sNDA approval
Mar 1, 2022 04:05PM Karyopharm Provides U.S. Regulatory Update on Selinexor in Advanced or Recurrent Endometrial Cancer
Feb 28, 2022 04:56PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 22, 2022 07:23AM Karyopharm Therapeutics (KPTI) CMO has stepped down to pursue other professional opportunities
Feb 22, 2022 07:00AM Karyopharm Announces Changes to Its Clinical Leadership Team
Feb 11, 2022 07:00AM Karyopharm to Participate at 11th Annual SVB Leerink Global Healthcare Conference
Feb 8, 2022 07:35AM Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
Feb 8, 2022 07:32AM Karyopharm Therapeutics (KPTI) Reports Phase 3 SIENDO Study Meets Primary Endpoint
Feb 8, 2022 07:30AM Karyopharm Announces Phase 3 SIENDO Study Meets Primary Endpoint with Statistically Significant Increase in Progression-Free Survival in Patients with Advanced or Recurrent Endometrial Cancer
Feb 2, 2022 07:00AM Karyopharm to Report Fourth Quarter and Full Year 2021 Financial Results on February 8, 2022
Feb 1, 2022 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 24, 2022 07:01AM Karyopharm Therapeutics (KPTI) Receives Orphan Drug Designation from FDA for Eltanexor for the Treatment of Myelodysplastic Syndromes
Jan 24, 2022 07:00AM Karyopharm Receives Orphan Drug Designation from FDA for Eltanexor for the Treatment of Myelodysplastic Syndromes
Jan 21, 2022 07:00AM Karyopharm to Present at B. Riley Securities Oncology Investor Conference
Jan 10, 2022 07:05AM Karyopharm Promotes Sohanya Cheng to Chief Commercial Officer
Jan 10, 2022 07:00AM Karyopharm Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Net Product Revenues and Outlines 2022 Objectives
Mar 2, 2020 09:24AM Pre-Open Stock Movers 03/02: (FTSV) (TRIL) (TWTR) Higher; (BIOC) (ENLV) (NVAX) Lower (more...)
Jul 11, 2019 09:01AM Karyopharm Therapeutics (KPTI) Announces Collaboration with Ivy Brain Tumor Center to Develop Tissue-Based Clinical Trial for Brain Cancer
Jul 11, 2019 09:00AM Ivy Brain Tumor Center and Karyopharm Therapeutics Collaborate to Develop Tissue-Based Clinical Trial for Brain Cancer
Mar 19, 2019 07:03AM Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance
Mar 19, 2019 07:00AM Life Sciences Companies Adopt Veeva Nitro to Eliminate the Burden of Custom Data Warehouse Development and Maintenance
Jan 25, 2018 06:34AM Biogen (BIIB) to Acquire Karyopharm Therapeutics (KPTI) KPT-350 for $10M and Up to $207M Additional
Jan 25, 2018 06:30AM Karyopharm Announces Agreement for Biogen to Acquire KPT-350 for the Treatment of Neurological and Neurodegenerative Conditions
Jan 25, 2018 06:30AM Karyopharm Announces Agreement for Biogen to Acquire KPT-350 for the Treatment of Neurological and Neurodegenerative Conditions
Apr 4, 2017 08:32AM Medidata (MDSO) Expands Partnership with Karyopharm Therapeutics (KPTI) to Bring Machine Learning to Clinical Oncology Trials
Apr 4, 2017 08:30AM Karyopharm and Medidata Expand Clinical Trial Partnership
Nov 3, 2016 10:00AM Karyopharm Therapeutics Inc. (Nasdaq: KPTI) to Ring The Nasdaq Stock Market Closing Bell
Aug 18, 2016 10:44AM Notable Analyst Rating Changes 8/18: (PCLN) (KMI) (TOO) Upgraded; (TWTR) (HMSY) (MMP) Downgraded
Feb 5, 2014 10:00AM Karyopharm Therapeutics Inc. [KPTI] to Ring The NASDAQ Stock Market Closing Bell
View More Recent Stories